or Try an Advanced Search...

    Genetic Testing Stocks List

    Symbol Grade Name % Change
    NTRA A Natera, Inc. -1.53
    PRE C Prenetics Global Limited -6.17
    ME D 23andMe Holding Co. -2.99
    OSUR F OraSure Technologies, Inc. -4.15
    NEOG F Neogen Corporation -2.90
    FLGT F Fulgent Genetics, Inc. -0.23
    GENE F Genetic Technologies Ltd -6.25
    AWH F Aspira Women's Health Inc. 1.02
    View As Page of Charts
    Related Industries: Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medical Test Applied Genetics Genetics Medical Genetics Medicine Biotechnology Genomics Biology Cancer Clinical Medicine DNA DNA Paternity Testing Diagnostic Products FDA Genetic Testing Services Immunoassay Ovarian Cancer Pharmacogenomics Toxicology Acid

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Testing stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 8.96
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 4.33
    FRTY C Alger Mid Cap 40 ETF 4.04
    HTEC D Robo Global Healthcare Technology and Innovation ETF 3.55
    ATFV C Alger 25 ETF 3.45
    View all Genetic Testing ETFs...
    Compare ETFs
    Compare EKG to HTEC Compare GNOM to ATFV Compare GNOM to EKG

        Genetic Testing Stocks Recent News

        Date Stock Title
        May 8 OSUR OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
        May 8 NTRA Natera Q1 2024 Earnings Preview
        May 8 OSUR OraSure Technologies Non-GAAP EPS of $0.04 beats by $0.01, revenue of $54.13M beats by $1.86M
        May 8 OSUR OraSure Reports Q1 ’24 Revenue of $54.1 Million
        May 8 NEOG Neogen® to Participate in the Bank of America 2024 Health Care Conference
        May 7 OSUR OraSure Technologies Q1 2024 Earnings Preview
        May 7 NEOG Neogen® to Participate in 2024 RBC Capital Markets Global Healthcare Conference
        May 6 FLGT Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 6 GENE GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
        May 4 FLGT Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
        May 4 FLGT Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
        May 4 FLGT Q1 2024 Fulgent Genetics Inc Earnings Call
        May 3 FLGT Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript
        May 3 FLGT Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses
        May 3 FLGT Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
        May 3 NTRA New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
        May 3 FLGT Fulgent Genetics reports mixed Q1 results; reaffirms FY24 outlook
        May 3 FLGT Fulgent Reports First Quarter 2024 Financial Results
        May 2 FLGT Fulgent Genetics Q1 2024 Earnings Preview
        Related Industries: Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Medical Test Applied Genetics Genetics Medical Genetics Medicine Biotechnology Genomics Biology Cancer Clinical Medicine DNA DNA Paternity Testing Diagnostic Products FDA Genetic Testing Services Immunoassay Ovarian Cancer Pharmacogenomics Toxicology Acid
        Genetic Testing

        Genetic testing is a type of medical test that looks at a person’s genes to identify changes that may be associated with a medical condition. It can be used to diagnose a variety of conditions, including inherited diseases, birth defects, and other health problems. It can also be used to determine a person’s risk of developing certain diseases in the future.

        Browse All Tags